EUDA Health Holdings (EUDA) EBITDA Margin (2022 - 2023)
EUDA Health Holdings' (EUDA) quarterly EBITDA Margin came in at 708.67% in Q2 2023, down 63750.0% year-over-year from N/an in Q2 2022, and down 508.99% quarter-over-quarter from 116.37% in Q1 2023.
Analysis
EUDA Health Holdings (EUDA) EBITDA Margin (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has reported EBITDA Margin for 2 consecutive years, with 708.67% the latest figure, recorded in Q2 2023.
- On a quarterly basis, EBITDA Margin fell 63750.0% year-over-year to 708.67% in Q2 2023; TTM through Jun 2023 was 209.92%, a N/A change from a year earlier, with the FY2025 full-year figure at 36.33%, up 39586.0% from the prior year.
- EBITDA Margin was 708.67% for Q2 2023 at EUDA Health Holdings, down from 116.37% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2.82% in Q1 2022 and troughed at 708.67% in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.74 Bn | 11.05 Bn | 1.16 Bn | 16.29% |
| 2 | RadNet | 5.78 Bn | 5.06 Bn | 88.08 Mn | 6.34% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 9.58% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 18.99% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 1.88% |
| 6 | Progyny | 2.12 Bn | 1.88 Bn | 89.30 Mn | 11.41% |
| 7 | Pediatrix Medical | 2.12 Bn | 1.71 Bn | - | 11.67% |
| 8 | Surgery Partners | 1.82 Bn | 1.60 Bn | 622.10 Mn | 12.03% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 10.25% |
| 10 | EUDA Health Holdings | 23.79 Mn | 23.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -708.67% |
| Mar 31, 2023 | -116.37% |
| Jun 30, 2022 | -71.17% |
| Mar 31, 2022 | 2.82% |